Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial
Seyed Hesameddin Abbasi, Payam Mohammadinejad, Nazila Shahmansouri, et al.
Journal of Affective Disorders (2015) Vol. 183, pp. 149-155
Closed Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories
Sameer Hassamal
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 163
Statins for the treatment of depression: A meta-analysis of randomized, double-blind, placebo-controlled trials
Estela Salagre, Brisa S. Fernandes, Seetal Dodd, et al.
Journal of Affective Disorders (2016) Vol. 200, pp. 235-242
Closed Access | Times Cited: 112
Statins and Inflammation: New Therapeutic Opportunities in Psychiatry
Sung‐Wan Kim, Hee‐Ju Kang, Min Jhon, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 109
Postoperative Cognitive Decline After Cardiac Surgery: A Narrative Review of Current Knowledge in 2019
Sandro Glumac, Goran Kardum, Nenad Karanović
Medical Science Monitor (2019) Vol. 25, pp. 3262-3270
Open Access | Times Cited: 108
Crocus sativus L. versus Citalopram in the Treatment of Major Depressive Disorder with Anxious Distress: A Double-Blind, Controlled Clinical Trial
Alireza Ghajar, Seyedeh Morvarid Neishabouri, N. Velayati, et al.
Pharmacopsychiatry (2016) Vol. 50, Iss. 04, pp. 152-160
Open Access | Times Cited: 100
Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients
Hamid Emadi-Kouchak, Payam Mohammadinejad, Ali Asadollahi‐Amin, et al.
International Clinical Psychopharmacology (2015) Vol. 31, Iss. 1, pp. 20-26
Closed Access | Times Cited: 70
Psychological and pharmacological interventions for depression in patients with coronary artery disease
Phillip J. Tully, Ser Yee Ang, Emily JL Lee, et al.
Cochrane library (2021) Vol. 2021, Iss. 12
Open Access | Times Cited: 53
Do statins have an effect on depressive symptoms? A systematic review and meta-analysis
Megha Sai Yatham, Kavya Sai Yatham, Arun Ravindran, et al.
Journal of Affective Disorders (2019) Vol. 257, pp. 55-63
Closed Access | Times Cited: 53
Riluzole combination therapy for moderate-to-severe major depressive disorder: A randomized, double-blind, placebo-controlled trial
Elaheh Salardini, Atefeh Zeinoddini, Payam Mohammadinejad, et al.
Journal of Psychiatric Research (2016) Vol. 75, pp. 24-30
Closed Access | Times Cited: 50
The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double‐blind and placebo‐controlled trial
Negar Iranpour, Atefeh Zandifar, Mehdi Farokhnia, et al.
Human Psychopharmacology Clinical and Experimental (2016) Vol. 31, Iss. 2, pp. 103-112
Closed Access | Times Cited: 47
Biocatalyzed Synthesis of Statins: A Sustainable Strategy for the Preparation of Valuable Drugs
Pilar Hoyos, Vittorio Pace, Andrés R. Alcántara
Catalysts (2019) Vol. 9, Iss. 3, pp. 260-260
Open Access | Times Cited: 47
Putative neuroprotective pharmacotherapies to target the staged progression of mental illness
Oliver D’Arcy Robertson, Nieves G. Coronado, Rickinder Sethi, et al.
Early Intervention in Psychiatry (2019) Vol. 13, Iss. 5, pp. 1032-1049
Open Access | Times Cited: 43
Statins for major depressive disorder: A systematic review and meta-analysis of randomized controlled trials
Riccardo De Giorgi, Franco De Crescenzo, Nicola Rizzo Pesci, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0249409-e0249409
Open Access | Times Cited: 39
Statins in Depression: An Evidence-Based Overview of Mechanisms and Clinical Studies
Riccardo De Giorgi, Nicola Rizzo Pesci, Alice M. G. Quinton, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 37
Cool the Inflamed Brain: A Novel Anti-inflammatory Strategy for the Treatment of Major Depressive Disorder
Wenjun Su, Ting Hu, Chun‐Lei Jiang
Current Neuropharmacology (2023) Vol. 22, Iss. 5, pp. 810-842
Closed Access | Times Cited: 12
Efficacy and safety of celecoxib monotherapy for mild to moderate depression in patients with colorectal cancer: A randomized double-blind, placebo controlled trial
Maryam Alamdarsaravi, Alireza Ghajar, Ahmad-Ali Noorbala, et al.
Psychiatry Research (2017) Vol. 255, pp. 59-65
Closed Access | Times Cited: 39
Celecoxib Versus Diclofenac in Mild to Moderate Depression Management Among Breast Cancer Patients
Payam Mohammadinejad, Pantea Arya, Mohsen Esfandbod, et al.
Annals of Pharmacotherapy (2015) Vol. 49, Iss. 9, pp. 953-961
Closed Access | Times Cited: 37
Effects of Saffron on Cognition, Anxiety, and Depression in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Double-Blind Placebo-Controlled Trial
Ehsan Moazen‐Zadeh, Seyed Hesameddin Abbasi, Hamideh Safi-Aghdam, et al.
The Journal of Alternative and Complementary Medicine (2017) Vol. 24, Iss. 4, pp. 361-368
Closed Access | Times Cited: 36
L-Carnosine combination therapy for major depressive disorder: A randomized, double-blind, placebo-controlled trial
Behin Araminia, Mohammadreza Shalbafan, Amirhosein Mortezaei, et al.
Journal of Affective Disorders (2020) Vol. 267, pp. 131-136
Closed Access | Times Cited: 29
Current Perspectives on Pharmacological and Non-Pharmacological Interventions for the Inflammatory Mechanism of Unipolar Depression
Ioana-Alexandra Dogaru, Maria Gabriela Puiu, Mirela Manea, et al.
Brain Sciences (2022) Vol. 12, Iss. 10, pp. 1403-1403
Open Access | Times Cited: 16
Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy
Nicola Tarantino, Francesco Santoro, Luisa De Gennaro, et al.
Vascular Health and Risk Management (2017) Vol. Volume 13, pp. 29-41
Open Access | Times Cited: 30
Update on Statin Treatment in Patients with Neuropsychiatric Disorders
Razieh Avan, Adeleh Sahebnasagh, Javad Hashemi, et al.
Life (2021) Vol. 11, Iss. 12, pp. 1365-1365
Open Access | Times Cited: 22
Do Statins Have Antidepressant Effects?
Ole Köhler‐Forsberg, Christiane Gasse, Michael Berk, et al.
CNS Drugs (2017) Vol. 31, Iss. 5, pp. 335-343
Closed Access | Times Cited: 27
Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trial
Christian Otte, Woo Ri Chae, Jan Nowacki, et al.
BMJ Open (2020) Vol. 10, Iss. 12, pp. e040119-e040119
Open Access | Times Cited: 21
Targeting Metabolic Dysfunction for the Treatment of Mood Disorders: Review of the Evidence
Brett D. M. Jones, Salman Farooqui, Stefan Kloiber, et al.
Life (2021) Vol. 11, Iss. 8, pp. 819-819
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top